{
    "2020-12-24": [
        [
            {
                "time": "2020-12-24",
                "original_text": "联通创投发起设立5G产业母基金，五连板郑州煤电风险提示",
                "features": {
                    "keywords": [
                        "5G产业母基金",
                        "郑州煤电",
                        "风险提示"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "通信",
                        "煤炭"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "白酒驾崩，行情被带沟里，妖股再新高！",
                "features": {
                    "keywords": [
                        "白酒",
                        "妖股",
                        "新高"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "恒瑞医药(SH600276)：SHR6390片的相关III期临床研究达到方案预设的优效标准",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR6390",
                        "临床研究",
                        "优效标准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "主力资金净流出449亿元，多只白酒股遭主力抛售",
                "features": {
                    "keywords": [
                        "主力资金",
                        "白酒股",
                        "抛售"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "今日50股创新高，多只医药股在列",
                "features": {
                    "keywords": [
                        "创新高",
                        "医药股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "恒瑞医药(SH600276)：SHR8028滴眼液获得药物临床试验批准通知书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR8028",
                        "滴眼液",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-24",
                "original_text": "市场调整引发主力出逃，410亿资金呈现净流出",
                "features": {
                    "keywords": [
                        "市场调整",
                        "主力出逃",
                        "资金流出"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}